Greg Zante

Greg Zante is currently the VP Finance & Operations at Viking Therapeutics. Prior to this, they served as the Senior Vice President of Finance for Viking Therapeutics from January 2016 to December 2020. From January 2013 to December 2016, Greg was the Chief Financial Officer for Dance Biopharm, Inc. From January 2001 to December 2003, they were the Senior Director of Finance and Administration for Calyx Therapeutics, Inc. From January 2000 to December 2001, Greg served as the Accounting Manager for Matrix Pharmaceuticals, Inc. And from January 1999 to December 2000, they were the Accounting Manager for Irwin Home Equity. Prior to that, Greg held the position of Senior Financial Analyst for ReSound Corporation from January 1995 to December 1997 and Senior Audit for Ernst & Young LLP from January 1993 to December 1995.

Greg Zante has a Bachelor of Arts in Business-Economics from the University of California, Los Angeles and is certified by the California Board of Accountancy as a CPA.

Their manager is Brian Lian, President & CEO. They work with Michael Morneau - VP Finance & Administration, Marianne Mancini - SVP Clinical Operations, and Amy Broidrick - SVP Corporate Development .